We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drug Industry Slams French Law Promoting Off-Label Use
Drug Industry Slams French Law Promoting Off-Label Use
EU biopharma groups have lodged a complaint with the European Commission opposing a French law that promotes off-label use of medicines, saying it puts cost ahead of patient safety.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor